Background: Tumour necrosis factor α (TNFα) may be an important mediator of insulin
resistance. Infliximab is a chimeric monoclonal, high affinity antibody against the soluble and …

OBJECTIVE: To investigate the longterm effects of the anti-tumor necrosis factor (TNF) therapy
infliximab, a drug known to reduce disease activity in patients with rheumatoid arthritis (RA…

Twenty‐one child patients with thalassaemic major (TM) and 83 healthy control children
were examined for dental caries and gingivitis. Stimulated parotid gland secretions were …

The majority of end-stage renal patients undergoing maintenance hemodialysis (HD) develop
anemia that adversely affects their quality of life and increases the risk for cardiovascular …

Hyperamylasemia is a common finding in chronic renal failure (CRF) patients. It has been
suggested that the diagnosis of acute pancreatitis in these patients is confirmed when serum …

Hyperamylasemia is a common finding in chronic renal failure (CRF) patients. The present
study was designed to evaluate the frequency, the type, and the hyperamylasemia levels in …

Diabetes is a complex metabolic disorder affecting the glucose status of the human body.
Chronic hyperglycaemia related to diabetes is associated with end organ failure. The clinical …

Diabetes is defined by a persistently elevated blood glucose concentration, leading to
complications that can be acute and long term. Acutely, marked hyperglycemia impairs water and …

The prevailing concentration of blood glucose is a result of the integrated regulation of
insulin secretion and insulin action. Nevertheless, the classic stereotypes of diabetes are …

… Kiortsis DN, Mavridis AK, Vasakos S, et al. Effects of infliximab treatment on insulin resistance
in patients with rheumatoid arthritis and ankylosing spondylitis. Ann Rheum Dis 2005; 64:…